dengue nonstructural 1 (DEN-NS1) antibody and antigen (Recombinant protein)

Diagnostic antibodies (anti-dengue nonstructural 1, anti-DEN-NS1) and antigens (recombinant protein) for Infectious disease dengue nonstructural 1 detection in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT.

Target products collectionGo to Infectious disease diagnostics products collection >>


Product information

Size: 1mg | 10mg | 100mg

Catalog No. Description US $ Price (per mg) First Order Discount First Order Discount Price
GMP-IVD-P040-Tg000-Ag01 Recombinant dengue nonstructural 1 (DEN-NS1) Protein 3090
GMP-IVD-P040-Tg000-Ab01 Anti-dengue nonstructural 1 (DEN-NS1) mouse monoclonal antibody (mAb) 1953 20% 1562.4
GMP-IVD-P040-Tg000-Ab02 Anti-dengue nonstructural 1 (DEN-NS1) mouse monoclonal antibody (mAb) 1953 20% 1562.4
GMP-IVD-P040-Tg000-Ab03 Anti-dengue nonstructural 1 (DEN-NS1) human monoclonal antibody (mAb) 1953 20% 1562.4
GMP-IVD-P040-Tg000-Ab04 Anti-dengue nonstructural 1 (DEN-NS1) human monoclonal antibody (mAb) 1953 20% 1562.4

Shipping Costs: $360–$760
Antibodies: $360 Antigens: $760 (Elevated cost due to antigen heterogeneity, post-translational modifications, structural complexity, and specialized handling.)



Product Description

Cat No. of Products GMP-IVD-P040-Tg000-Ag01
Product Name Recombinant dengue nonstructural 1 (DEN-NS1) Protein
Pathogen dengue nonstructural 1
Target/Biomarker
Expression platform E.coli
Isotypes Recombinant Antigen
Bioactivity validation dengue nonstructural 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in dengue nonstructural 1 level test of Infectious disease (dengue) and related syndrome evaluation.
Tag His
Products description Recombinant dengue nonstructural 1 (DEN-NS1) Protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA) and Immunonephelometry.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-IVD-P040-Tg000-Ab01, GMP-IVD-P040-Tg000-Ab02
Product Name Anti-dengue nonstructural 1 (DEN-NS1) mouse monoclonal antibody (mAb)
Pathogen dengue nonstructural 1
Target/Biomarker
Expression platform CHO
Isotypes Mouse IgG
Bioactivity validation dengue nonstructural 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in dengue nonstructural 1 level test of Infectious disease (dengue) and related syndrome evaluation.
Tag mFc
Products description Anti-dengue nonstructural 1 (DEN-NS1) mouse monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Cat No. of Products GMP-IVD-P040-Tg000-Ab03, GMP-IVD-P040-Tg000-Ab04
Product Name Anti-dengue nonstructural 1 (DEN-NS1) human monoclonal antibody (mAb)
Pathogen dengue nonstructural 1
Target/Biomarker
Expression platform CHO
Isotypes Human lgG1
Bioactivity validation dengue nonstructural 1 antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in dengue nonstructural 1 level test of Infectious disease (dengue) and related syndrome evaluation.
Tag hFc
Products description Anti-dengue nonstructural 1 (DEN-NS1) human monoclonal antibody (mAb) was expressed in CHO - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
Purity Purity: ≥95% (SDS-PAGE)
Application ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker information

    D-dimer (or D dimer) is a fibrin degradation product (or FDP), a small protein fragment present in the blood after a blood clot is degraded by fibrinolysis. It is so named because it contains two D fragments of the fibrin protein joined by a cross-link.[1] D-dimer concentration may be determined by a blood test to help diagnose thrombosis.[2] Since its introduction in the 1990s, it has become an important test performed in people with suspected thrombotic disorders, such as venous thromboembolism.[2][3] While a negative result practically rules out thrombosis, a positive result can indicate thrombosis, but does not exclude other potential causes.[3] Its main use, therefore, is to exclude thromboembolic disease where the probability is low.[1][2] D-dimer levels are used as a predictive biomarker for the blood disorder, disseminated intravascular coagulation and in the coagulation disorders associated with COVID-19 infection.[1][3] A four-fold increase in the protein is an indicator of poor prognosis in people hospitalized with COVID-19.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.

    Comments


    No comments yet.

    Leave a comment